Published online before print February 27, 2003, doi: 10.1161/01.RES.0000063425.51108.8D
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Heart Association, Inc.
Integrative Physiology |
Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats
From the Department of Neurology (J.C., Z.G.Z., Y.L., L.W., M.C.), Division of Hematology/Oncology (Y.X.X., S.C.G.), Biostatistics and Research Epidemiology (M.L.), Henry Ford Health Sciences Center, Detroit, Mich; the Department of Antibody Technology (Z.Z.), ImClone Systems Incorporated, New York, NY; and the Department of Physics (M.C.), Oakland University, Rochester, Mich.
Correspondence to Michael Chopp, PhD, Neurology Research, E&R Bldg, Rm 3056, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu
We tested the hypothesis that intravenous infusion of human bone marrow stromal cells (hMSCs) promotes vascular endothelial growth factor (VEGF) secretion, VEGF receptor 2 (VEGFR2) expression and angiogenesis in the ischemic boundary zone (IBZ) after stroke. hMSCs (1x106) were intravenously injected into rats 24 hours after middle cerebral artery occlusion (MCAo). Laser scanning confocal microscopy (LSCM), immunohistochemistry and ELISA were performed to assay angiogenesis and levels of human and rat VEGF in the host brain, respectively. In addition, capillary-like tube formation was measured using mouse brain-derived endothelial cells (MBDECs). Morphological and three dimensional image analyses revealed significant (P<0.05) increases in numbers of enlarged and thin walled blood vessels and numbers of newly formed capillaries at the boundary of the ischemic lesion in rats (n=12) treated with hMSCs compared with numbers in rats (n=12) treated with PBS. ELISA measurements showed that treatment with hMSCs significantly (P<0.05) raised endogenous rat VEGF levels in the IBZ from 10.5±1.7 ng/mL in the control group to 17.5±1.6 ng/mL in the hMSC-treated group. In addition, treatment with hMSCs increased endogenous VEGFR2 immunoreactivity. In vitro, when MBDECs were incubated with the supernatant obtained from cultured hMSCs, capillary-like tube formation was significantly (P<0.01) induced. However, hMSC-induced capillary-like tube formation was significantly (P<0.01) inhibited when the endothelial cells were incubated with the supernatant from hMSCs in the presence of a neutralizing anti-VEGFR2. These data suggest that treatment of stroke with hMSCs enhances angiogenesis in the host brain and hMSC-enhanced angiogenesis is mediated by increases in levels of endogenous rat VEGF and VEGFR2.
Key Words: middle cerebral artery occlusion • bone marrow stromal cell • angiogenesis • vascular endothelial growth factor • rats
This article has been cited by other articles:
 |
|
 |
|
  M. Chopp, Y. Li, and Z. G. Zhang Mechanisms Underlying Improved Recovery of Neurological Function After Stroke in the Rodent After Treatment With Neurorestorative Cell-Based Therapies Stroke, March 1, 2009; 40(3_suppl_1): S143 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cai, R. Guzman, A. R. Hsu, H. Wang, K. Chen, G. Sun, A. Gera, R. Choi, T. Bliss, L. He, et al. Positron Emission Tomography Imaging of Poststroke Angiogenesis Stroke, January 1, 2009; 40(1): 270 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1 J. Neurosci., November 26, 2008; 28(48): 12788 - 12797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schwarting, S. Litwak, W. Hao, M. Bahr, J. Weise, and H. Neumann Hematopoietic Stem Cells Reduce Postischemic Inflammation and Ameliorate Ischemic Brain Injury Stroke, October 1, 2008; 39(10): 2867 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, Y. Li, X. Zhang, S. Savant-Bhonsale, and M. Chopp Contralesional Axonal Remodeling of the Corticospinal System in Adult Rats After Stroke and Bone Marrow Stromal Cell Treatment Stroke, September 1, 2008; 39(9): 2571 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Kim, S.-W. Yoo, T.-S. Park, S.-C. Ahn, H.-S. Jeong, J.-W. Kim, D.-Y. Chang, K.-G. Cho, S. U. Kim, Y. Huh, et al. Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain Stem Cells, September 1, 2008; 26(9): 2217 - 2228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts Stroke, July 1, 2008; 39(7): 2158 - 2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cui, J. Chen, A. Zacharek, Y. Li, C. Roberts, A. Kapke, S. Savant-Bhonsale, and M. Chopp Nitric Oxide Donor Upregulation of Stromal Cell-Derived Factor-1/Chemokine (CXC Motif) Receptor 4 Enhances Bone Marrow Stromal Cell Migration into Ischemic Brain After Stroke Stem Cells, November 1, 2007; 25(11): 2777 - 2785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Hung, R. R. Pochampally, S.-C. Chen, S.-C. Hsu, and D. J. Prockop Angiogenic Effects of Human Multipotent Stromal Cell Conditioned Medium Activate the PI3K-Akt Pathway in Hypoxic Endothelial Cells to Inhibit Apoptosis, Increase Survival, and Stimulate Angiogenesis Stem Cells, September 1, 2007; 25(9): 2363 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, N. Ma, L.-L. Ong, C. Nesselmann, C. Klopsch, Y. Ladilov, D. Furlani, C. Piechaczek, J. M. Moebius, K. Lutzow, et al. Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function Stem Cells, August 1, 2007; 25(8): 2118 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Shi, T. Kazui, X. Jiang, N. Washiyama, K. Yamashita, H. Terada, and A. H. M. Bashar Therapeutic Benefit of Intrathecal Injection of Marrow Stromal Cells on Ischemia-Injured Spinal Cord Ann. Thorac. Surg., April 1, 2007; 83(4): 1484 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Baker, V. Sica, L. M. Work, S. Williams-Ignarro, F. de Nigris, L. O. Lerman, A. Casamassimi, A. Lanza, C. Schiano, M. Rienzo, et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia PNAS, February 27, 2007; 104(9): 3597 - 3602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bliss, R. Guzman, M. Daadi, and G. K. Steinberg Cell Transplantation Therapy for Stroke Stroke, February 1, 2007; 38(2): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Long, W. Mu, K. L. Price, C. Roncal, G. F. Schreiner, A. S. Woolf, and R. J. Johnson Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1248 - F1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Shi, T. Kazui, X. Jiang, N. Washiyama, K. Yamashita, H. Terada, and A. H. M. Bashar Intrathecal Injection of Bone Marrow Stromal Cells Attenuates Neurologic Injury After Spinal Cord Ischemia Ann. Thorac. Surg., June 1, 2006; 81(6): 2227 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Min, X. Huang, M. Xiang, A. Meissner, Y. Chen, Q. Ke, E. Kaplan, J. S. Rana, P. Oettgen, and J. P. Morgan Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, C.-Y. Su, and H. Li Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J. Neurosci., March 29, 2006; 26(13): 3444 - 3453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Shyu, S.-Z. Lin, C.-C. Lee, D. D. Liu, and H. Li Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial Can. Med. Assoc. J., March 28, 2006; 174(7): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, Z. G. Zhang, G. L. Ding, Q. Jiang, X. Liu, H. Meng, A. Hozeska, C. Zhang, L. Li, D. Morris, et al. Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat Circulation, November 29, 2005; 112(22): 3486 - 3494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hanabusa, N. Nagaya, T. Iwase, T. Itoh, S. Murakami, Y. Shimizu, W. Taki, K. Miyatake, and K. Kangawa Adrenomedullin Enhances Therapeutic Potency of Mesenchymal Stem Cells After Experimental Stroke in Rats Stroke, April 1, 2005; 36(4): 853 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagaya, T. Fujii, T. Iwase, H. Ohgushi, T. Itoh, M. Uematsu, M. Yamagishi, H. Mori, K. Kangawa, and S. Kitamura Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2670 - H2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang, O. A. Carretero, X.-Y. Yang, N.-E. Rhaleb, Y.-H. Liu, T.-D. Liao, and X.-P. Yang N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2099 - H2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Shyu, S.-Z. Lin, H.-I Yang, Y.-S. Tzeng, C.-Y. Pang, P.-S. Yen, and H. Li Functional Recovery of Stroke Rats Induced by Granulocyte Colony-Stimulating Factor-Stimulated Stem Cells Circulation, September 28, 2004; 110(13): 1847 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats Stroke, July 1, 2004; 35(7): 1732 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Barbash, P. Chouraqui, J. Baron, M. S. Feinberg, S. Etzion, A. Tessone, L. Miller, E. Guetta, D. Zipori, L. H. Kedes, et al. Systemic Delivery of Bone Marrow-Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution Circulation, August 19, 2003; 108(7): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. Buschmann, H.-J. Busch, G. Mies, and K.-A. Hossmann Therapeutic Induction of Arteriogenesis in Hypoperfused Rat Brain Via Granulocyte-Macrophage Colony-Stimulating Factor Circulation, August 5, 2003; 108(5): 610 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Anversa, J. Kajstura, B. Nadal-Ginard, and A. Leri Primitive Cells and Tissue Regeneration Circ. Res., April 4, 2003; 92(6): 579 - 582. [Full Text] [PDF]
|
|